Liver cancer screening in Korea: A report on the 2008 national cancer screening programme

Eun Ha Lee, Mi Ah Han, Hoo Yeon Lee, Jae Kwan Jun, Kui Son Choi, Euncheol Park

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: The Korean National Cancer Screening Programme (NCSP) for liver cancer was initiated in 2003. The objective of this study was to evaluate participation in the NCSP and provide essential evidence associated with the screening of Korean adults at high risk for liver cancer. Methods: Liver cancer screening was conducted in two stages. During the first, the fraction of the population at high risk for liver cancer was identified through detection of the hepatitis B virus surface antigen (HBsAg) and hepatitis C virus antibodies (anti-HCV Ab). During the second stage, this high-risk population was kept under surveillance to detect liver cancers as quickly as possible, and screening participation rates and recall rates were assessed. We estimated the 95% confidence intervals (CIs) for all outcome measures. Results: In the first stage, 2.57% (95% CI, 2.47-2.67) of Medical Aid Programme (MAP) recipients tested positive for HBsAg and 3.70% (95% CI, 3.25-4.15) tested positive for anti-HCV Ab. The total target population for liver cancer screening in 2008 included 433,822 adults over 40 years of age. Of them, 141,381 (32.6%) participated in the NCSP for liver cancer. Participation rates were 34.9% for National Health Insurance (NHI) recipients and 25.2% for MAP recipients. Among participants, 1,139 individuals exhibited a positive screening result (recall rate = 0.81%). Conclusions: Our findings demonstrate the current status of liver cancer screening in Korea. They provide evidence for implementing an organised liver cancer screening programme among high-risk groups.

Original languageEnglish
Pages (from-to)1305-1310
Number of pages6
JournalAsian Pacific Journal of Cancer Prevention
Volume11
Issue number5
Publication statusPublished - 2010 Jan 1

Fingerprint

Liver Neoplasms
Korea
Early Detection of Cancer
Confidence Intervals
Hepatitis B Surface Antigens
Hepatitis B virus
Hepatitis C Antibodies
Health Services Needs and Demand
National Health Programs
Outcome Assessment (Health Care)

All Science Journal Classification (ASJC) codes

  • Epidemiology
  • Oncology
  • Public Health, Environmental and Occupational Health
  • Cancer Research

Cite this

Lee, Eun Ha ; Han, Mi Ah ; Lee, Hoo Yeon ; Jun, Jae Kwan ; Choi, Kui Son ; Park, Euncheol. / Liver cancer screening in Korea : A report on the 2008 national cancer screening programme. In: Asian Pacific Journal of Cancer Prevention. 2010 ; Vol. 11, No. 5. pp. 1305-1310.
@article{4c94d45f10824da69478453f0293491c,
title = "Liver cancer screening in Korea: A report on the 2008 national cancer screening programme",
abstract = "Background: The Korean National Cancer Screening Programme (NCSP) for liver cancer was initiated in 2003. The objective of this study was to evaluate participation in the NCSP and provide essential evidence associated with the screening of Korean adults at high risk for liver cancer. Methods: Liver cancer screening was conducted in two stages. During the first, the fraction of the population at high risk for liver cancer was identified through detection of the hepatitis B virus surface antigen (HBsAg) and hepatitis C virus antibodies (anti-HCV Ab). During the second stage, this high-risk population was kept under surveillance to detect liver cancers as quickly as possible, and screening participation rates and recall rates were assessed. We estimated the 95{\%} confidence intervals (CIs) for all outcome measures. Results: In the first stage, 2.57{\%} (95{\%} CI, 2.47-2.67) of Medical Aid Programme (MAP) recipients tested positive for HBsAg and 3.70{\%} (95{\%} CI, 3.25-4.15) tested positive for anti-HCV Ab. The total target population for liver cancer screening in 2008 included 433,822 adults over 40 years of age. Of them, 141,381 (32.6{\%}) participated in the NCSP for liver cancer. Participation rates were 34.9{\%} for National Health Insurance (NHI) recipients and 25.2{\%} for MAP recipients. Among participants, 1,139 individuals exhibited a positive screening result (recall rate = 0.81{\%}). Conclusions: Our findings demonstrate the current status of liver cancer screening in Korea. They provide evidence for implementing an organised liver cancer screening programme among high-risk groups.",
author = "Lee, {Eun Ha} and Han, {Mi Ah} and Lee, {Hoo Yeon} and Jun, {Jae Kwan} and Choi, {Kui Son} and Euncheol Park",
year = "2010",
month = "1",
day = "1",
language = "English",
volume = "11",
pages = "1305--1310",
journal = "Asian Pacific Journal of Cancer Prevention",
issn = "1513-7368",
publisher = "Asian Pacific Organization for Cancer Prevention",
number = "5",

}

Liver cancer screening in Korea : A report on the 2008 national cancer screening programme. / Lee, Eun Ha; Han, Mi Ah; Lee, Hoo Yeon; Jun, Jae Kwan; Choi, Kui Son; Park, Euncheol.

In: Asian Pacific Journal of Cancer Prevention, Vol. 11, No. 5, 01.01.2010, p. 1305-1310.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Liver cancer screening in Korea

T2 - A report on the 2008 national cancer screening programme

AU - Lee, Eun Ha

AU - Han, Mi Ah

AU - Lee, Hoo Yeon

AU - Jun, Jae Kwan

AU - Choi, Kui Son

AU - Park, Euncheol

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Background: The Korean National Cancer Screening Programme (NCSP) for liver cancer was initiated in 2003. The objective of this study was to evaluate participation in the NCSP and provide essential evidence associated with the screening of Korean adults at high risk for liver cancer. Methods: Liver cancer screening was conducted in two stages. During the first, the fraction of the population at high risk for liver cancer was identified through detection of the hepatitis B virus surface antigen (HBsAg) and hepatitis C virus antibodies (anti-HCV Ab). During the second stage, this high-risk population was kept under surveillance to detect liver cancers as quickly as possible, and screening participation rates and recall rates were assessed. We estimated the 95% confidence intervals (CIs) for all outcome measures. Results: In the first stage, 2.57% (95% CI, 2.47-2.67) of Medical Aid Programme (MAP) recipients tested positive for HBsAg and 3.70% (95% CI, 3.25-4.15) tested positive for anti-HCV Ab. The total target population for liver cancer screening in 2008 included 433,822 adults over 40 years of age. Of them, 141,381 (32.6%) participated in the NCSP for liver cancer. Participation rates were 34.9% for National Health Insurance (NHI) recipients and 25.2% for MAP recipients. Among participants, 1,139 individuals exhibited a positive screening result (recall rate = 0.81%). Conclusions: Our findings demonstrate the current status of liver cancer screening in Korea. They provide evidence for implementing an organised liver cancer screening programme among high-risk groups.

AB - Background: The Korean National Cancer Screening Programme (NCSP) for liver cancer was initiated in 2003. The objective of this study was to evaluate participation in the NCSP and provide essential evidence associated with the screening of Korean adults at high risk for liver cancer. Methods: Liver cancer screening was conducted in two stages. During the first, the fraction of the population at high risk for liver cancer was identified through detection of the hepatitis B virus surface antigen (HBsAg) and hepatitis C virus antibodies (anti-HCV Ab). During the second stage, this high-risk population was kept under surveillance to detect liver cancers as quickly as possible, and screening participation rates and recall rates were assessed. We estimated the 95% confidence intervals (CIs) for all outcome measures. Results: In the first stage, 2.57% (95% CI, 2.47-2.67) of Medical Aid Programme (MAP) recipients tested positive for HBsAg and 3.70% (95% CI, 3.25-4.15) tested positive for anti-HCV Ab. The total target population for liver cancer screening in 2008 included 433,822 adults over 40 years of age. Of them, 141,381 (32.6%) participated in the NCSP for liver cancer. Participation rates were 34.9% for National Health Insurance (NHI) recipients and 25.2% for MAP recipients. Among participants, 1,139 individuals exhibited a positive screening result (recall rate = 0.81%). Conclusions: Our findings demonstrate the current status of liver cancer screening in Korea. They provide evidence for implementing an organised liver cancer screening programme among high-risk groups.

UR - http://www.scopus.com/inward/record.url?scp=79955955338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955955338&partnerID=8YFLogxK

M3 - Article

C2 - 21198282

AN - SCOPUS:79955955338

VL - 11

SP - 1305

EP - 1310

JO - Asian Pacific Journal of Cancer Prevention

JF - Asian Pacific Journal of Cancer Prevention

SN - 1513-7368

IS - 5

ER -